Botswana Pharmaceuticals and Healthcare Report Q3 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Botswana Pharmaceuticals and Healthcare Report Q3 2013 May 1st 2013, 00:00 BMI View: Government''s commitment to healthcare and growing economy will continue to be key driversthat will attract foreign pharmaceutical firms to Botswana over the long term. However, BMI maintainsthat the country needs to see significant improvements in various areas such as its healthcare deliveryservices, population''s affluence and general improvements to its living standards before the country can seemajor investments from foreign pharmaceutical firms.Headline Expenditure Projections:Pharmaceuticals: BWP1.50bn (US$200mn) in 2012 to BWP1.66bn (US$200mn) in 2013; +10.1% in localcurrency terms and +0.4% in US dollar terms. Forecast in line with Q212....

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions